Partial breast re-irradiation using ultra hypofractionation (PRESERVE) Phase 2 multi-institutional study
PRESERVE: 1-week radiation study treatment
Sponsor: Canadian Cancer Society
Enrolling: Male and Female Patients
IRB Number: AAAV5572
Contact: Christina Chesnakov: / cc4047@cumc.columbia.edu
Additional Study Information: The purpose of this study is to see if a 1-week course of radiation therapy, called hypofractionated radiation therapy, is a safe and effective option for women with localized recurrent breast cancer who have already had radiation treatment. Hypofractionated radiation therapy is a type of cancer treatment that involves delivering a larger dose of radiation in fewer sessions. Normally, radiation for breast cancer involves smaller doses given over many sessions, often taking several weeks to complete. However, studies in women with newly diagnosed breast cancer (who haven't had radiation before) have shown that receiving fewer treatments with higher daily doses can be just as effective, more convenient, and cause fewer short-term side effects. This study aims to find out if hypofractionated radiation therapy is also a good option for women with recurrent breast cancer. If successful, it could provide a faster and easier treatment alternative to the traditional longer radiation schedule.
This study is closed
Investigator
Eileen Connolly, MD, PhD
Do You Qualify?
Are you 18 years or older? Yes No
have you been diagnosed with in-breast recurrence of DCIS or invasive carcinoma? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder


CAPTCHA
Image CAPTCHA
Enter the characters shown in the image.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.


For more information, please contact:
Christina Chesnakov
cc4047@cumc.columbia.edu